The impact of anticoagulation guidelines and low molecular weight heparin therapeutic substitution on resource utilization in a community hospital.

被引：0
|
作者：
Noviasky, JA
Gaffney, BJ
Iqbal, A
Bushnell, J
机构：
[1] Mohawk Valley Heart Inst, Utica, NY USA
[2] St Elizabeth Hosp, Utica, NY USA
来源：
PHARMACOTHERAPY | 2002年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
360
引用
收藏
页码：1382 / 1382
页数：1
相关论文
共 50 条
  • [1] Impact of an anticoagulation clinic in a community hospital.
    Johnson, SC
    Dhami, MS
    Fenton, MA
    Jagathambal, K
    Slater, DE
    Wellner, VL
    [J]. BLOOD, 1997, 90 (10) : 3235 - 3235
  • [2] Impact of low-molecular-weight heparin practice guidelines in a geriatric hospital
    d'Arailh, Lydie
    Gaubert-Dahan, Marie-Line
    Muller, Florence
    Lechowski, Laurent
    Teillet, Laurent
    [J]. GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (02): : 179 - 188
  • [3] The impact of multiple dose inhalers sharing program on utilization resource in a community hospital.
    Noviasky, JA
    Bushnell, JP
    Ritzel, C
    Stone, J
    Kokoszki, L
    Bramley, J
    [J]. PHARMACOTHERAPY, 2003, 23 (03): : 411 - 411
  • [4] IMPACT OF THERAPEUTIC GUIDELINES ON UTILIZATION PATTERN OF LOW MOLECULAR WEIGHT HEPARINS AT A SOUTH INDIAN TERTIARY CARE TEACHING HOSPITAL
    Adepu, R.
    Ariyappallil, A. J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A41 - A41
  • [5] Low-molecular-weight heparin as bridging anticoagulation
    van Dongen, CJ
    Vink, R
    Levi, M
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) : 2500 - 2500
  • [6] Intravenous pharmacokinetics and pharmacodynamics of a low molecular weight heparin (Enoxaparin) in cats: Impact on anticoagulation
    McGeehan, E.
    Alwood, A. J.
    Azarafrooz, F.
    Buesing, R.
    Hoppensteadt, D.
    Cera, L. M.
    Fareed, J.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2007, 46 (04): : 132 - 132
  • [7] Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin
    Nasser, NJ
    Sarig, G
    Brenner, B
    Nevo, E
    Goldshmidt, O
    Zcharia, E
    Li, JP
    Vlodavsky, I
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) : 560 - 565
  • [8] IS ANTICOAGULATION WITH LOW-MOLECULAR-WEIGHT HEPARIN SUPERIOR TO UNFRACTIONATED HEPARIN IN HEMODIALYSIS
    LAUBENTHAL, F
    PLUM, J
    SPRENGER, KBG
    GRABENSEE, B
    [J]. NIEREN-UND HOCHDRUCKKRANKHEITEN, 1989, 18 (11) : 488 - 493
  • [9] In vitro anticoagulation monitoring of low-molecular-weight heparin
    WANG JianqiSHI XuboYANG Jingang and HU Dayi Department of Cardiovascular CenterBeijing Tongren HospitalAffiliated to Capital Medical UniversityBeijing China Department of CardiologyCardiovascular Institute Fu WaiHospitalChinese Academy of Medical Sciences Peking UnionMedical CollegeBeijing China Department of CardiologyPeking University Peoples HospitalBeijing China
    [J]. 中华医学杂志(英文版), 2009, (10) : 1199 - 1202
  • [10] In vitro anticoagulation monitoring of low-molecular-weight heparin
    Wang Jian-qi
    Shi Xu-bo
    Yang Jin-gang
    Hu Da-yi
    [J]. CHINESE MEDICAL JOURNAL, 2009, 122 (10) : 1199 - 1202
12345